LifeScience Biologics
EDIRNA is a start-up biotech company focusing on RNA-Editing therapeutics and taking advantage of the Group's proprietary technology platforms for novel RN...
July 06, 2023 | News
Biotium, a leading provider of innovative life science solutions, is thrilled to announce the release of its latest product, Mix-n-Stain™ CF® Dye...
July 04, 2023 | News
Building on the success of this initial partnership, on June 4, 2023, Waters and Sartorius announced a new phase of their joint efforts. This time, the col...
July 03, 2023 | News
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...
July 03, 2023 | News
This marks Cresilon's first FDA clearance for human use, validating its revolutionary hemostatic gel technology and the company's global mission to transfo...
June 30, 2023 | News
BGI Genomics prioritizes compliance management and strictly follows laws, regulations, and international practices while conducting business globally. BGI ...
June 30, 2023 | News
Thermo Fisher Scientific, a global leading company in science services, today announced the launch of the Gibco™ OncoPro™ tumor media kit. *, t...
June 29, 2023 | News
By using this cutting-edge imaging technology in preclinical studies, Oncodesign Services’ team hopes to gain insights of the predictive effectivenes...
June 29, 2023 | News
The strategic agreement combines the capacity and capabilities of OBiO process development (PD) scientists with enabling platforms and support from...
June 28, 2023 | News
MINJUVI® (tafasitamab) provisionally approved by Therapeutic Goods Administration[1] Recent five-year follow-up data from Phase 2 L-MIND investig...
June 28, 2023 | News
INOVIQ's SubB2M/CA15-3 breast cancer test detects all-stages of breast cancer with excellent accuracy (87%), sensitivity (81%) and specificity (93%) The...
June 28, 2023 | News
Under the agreement, Innovent will provide clinical drug supplies of TYVYT® (sintilimab injection) during the clinical trial collaboration. RemeGen wil...
June 26, 2023 | News
Company acquires exclusive global rights of the novel lipopeptide BRII-693 for the difficult to treat MDR/XDR gram-negative bacterial infections &nbs...
June 26, 2023 | News
Cognigenics CEO John L. Mee announces breakthrough results from an animal study published today in PNAS Nexus. The findings point to the pot...
June 23, 2023 | Analysis
Most Read
Bio Jobs
News